Preferred Label : tegafur-gimeracil-oteracil;
Origin ID : C586502;
UMLS CUI : C3851369;
CISMeF manual mappings
- MeSH indexing information
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
https://www.has-sante.fr/jcms/p_3428419/fr/teysuno-gimeracil/tegafur/oteracil-cancer-colorectal
2023
false
false
false
France
tegafur-gimeracil-oteracil
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
tegafur, combinations
neoplasm metastasis
antineoplastic agents
drug combinations
tegafur
gimeracil
oxonic acid
evaluation of the transparency committee
colorectal neoplasms
---
http://www.has-sante.fr/portail/jcms/c_1329540/teysuno
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/teysuno__03102012_avis_ct12048.pdf
2012
false
France
French
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
drug combinations
administration, oral
gimeracil
gimeracil
adult
stomach neoplasms
antineoplastic combined chemotherapy protocols
tegafur
tegafur
oxonic acid
oxonic acid
tegafur, combinations
antineoplastic agents
antineoplastic agents
insurance, health, reimbursement
evaluation of the transparency committee
treatment outcome
randomized controlled trials as topic
survival analysis
pyridines
pyridines
drug combinations
drug combinations
---
https://www.ema.europa.eu/medicines/human/EPAR/Teysuno
2012
false
United Kingdom
French
English
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
syndication feed
tegafur
gimeracil
oxonic acid
drug combinations
gimeracil
tegafur
oxonic acid
drug approval
treatment outcome
pyridines
pyridines
tegafur, combinations
administration, oral
adult
antineoplastic agents
antineoplastic agents
stomach neoplasms
antineoplastic combined chemotherapy protocols
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pyridines
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug combinations
---
